Brief: Immunovia Q3 Net Loss Narrows To SEK 23 Mln
Nov 10 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA PUBLISHES INTERIM REPORT JAN-SEP 2022
* Q3 NET SALES AMOUNT KSEK 358 (377) DIVIDED BY SALES OF
TESTS
KSEK 111 AND ROYALTIES KSEK 247.
* Q3 NET EARNINGS AMOUNT MSEK -23 (-36)
Source text for Eikon: ID:nWkr6nPcYM
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study